Latest Publication
Bioconjugate Chemistry today published "Comparison of Pretargeted and Conventional CC49 Radioimmunotherapy Using ¹⁴⁹Pm, ¹⁶⁶Ho, and ¹⁷⁷Lu."

Dillon Kopecky presented McMillan Memorial Scholarship
Dillon Kopecky, a chemistry student at Brazosport College, was presented the 3^rd annual McMillan Memorial Scholarship

IsoTherapeutics Group has expanded its facilities and capabilities to include cGMP manufacturing. Our focus will be clinical trial scale radiopharmaceuticals.

Sophia Nadirshina recently received the IsoTherapeutics Group Kenneth McMillan Memorial Scholarship. Nadirshina, a chemistry major, plans to transfer to a university next school year followed by dental school.

"Liquid Brachytherapy," a novel technology for the treatment of inoperable tumors, jointly developed by IsoTherapeutics and The Gabriel Institute, has now been evaluated in 16 cases of canine osteosarcoma with very promising results. The latest treatment on "Juno," a 160 lb Saint Bernard was preformed at the new Texas A&M Institute for Preclinical Studies (TIPS). This was, in fact, the first clinical case treated at the new facility. TIPS brings state-of-the-art imaging capabilities to our efforts to move this technology forward. Juno's treatment was featured recently in MIT Technology Review.

Sara Barge, Biomedical Science major at Brazosport College, was presented with the first annual Kenneth McMillan Memorial Scholarship.

Veterinary Cancer Society - Austin, TX
"Intralesional Liquid Brachytherapy in Dogs with Appendicular Osteosarcoma"

Congratulations to Sara Barge, a Biomedical Science major at Brazosport College. She is the first recipient of the Kenneth McMillan Memorial Scholarship.

Due to many recent inquiries about a relationship between IsoTherapeutics and PharmaCom BioVet Inc., IsoTherapeutics wishes to state that we have no current relationship with this company.

The Kenneth McMillan Memorial Scholarship is being initiated to honor the memory of our late long-term friend and colleague Kenneth McMillan.  The scholarship will be awarded annually to a deserving high school senior from the Brazosport Independent School District.  Kenneth had a long career at The Dow Chemical Company, working along side us for over twenty years.  When we formed IsoTherapeutics, Kenneth joined us and served as our Radiation Safety Officer and Laboratory Director until his untimely passing in December of 2008.

Texas Life Science Conference - Houston, TX
"Liquid Brachytherapy"

Conference on the Application of Accelerators in Research and Industry
"Liquid Brachytherapy - Direct Administration of Therapeutic Isotopes into Tumors"

Society of Nuclear Medicine Annual Meeting - New Orleans, LA
"Liquid Brachytherapy - Direct Administration of Therapeutic Isotopes into Tumors"

University of Missouri School of Veterinary Medicine
Dr. Carolyn Henry and Dr. James Latimer